Mental Health in Austrian Teenagers (MHAT)

Mental Disorders Clinical Trial

— MHAT  

Official title:

The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03301077
• Other study ID #: FA765A0303
• Status: Completed
• Start date: January 2013
• Est. completion date: April 2015

Study information

• Verified date: March 2019
• Source: Medical University of Vienna
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Description:

Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents.

The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5):

1. Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life.

2. Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4000
• Est. completion date: April 2015
• Est. primary completion date: April 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 10 Years to 18 Years

Eligibility

Inclusion Criteria:

• adolescents aged 10-18

Exclusion Criteria:

• no written informed consent possible due to intelligence or no willingness by parents to include minor

Related Conditions & MeSH terms

• Mental Disorders
• Psychotic Disorders

Intervention

Other:
• 2-phase epidemiological study (screening, interviews)
first phase is the screening phase, second phase is the interview phase

Locations

Country	Name	City	State
Austria	Medical University of Vienna, Dep. of Child and Adolescent Psychiatry	Vienna

Sponsors (3)

Lead Sponsor	Collaborator
Medical University of Vienna	Ludwig Boltzmann Institute Health Promotion Research, Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)	Screening and interview	12 months
Secondary	rates of behavioral, emotional and social problems (representation of data collected at interview)	YSR (Youth Self Report) questionnaire	12 months
Secondary	psychiatric disorder related risks and protective factors (representation of data collected at interviews)	Kinder-DIPS (Diagnostisches Interview psychischer Störungen) interview	12 months
Secondary	quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)	KIDSCREEN (Kidscreen) questionnaire	12 months

External Links

•   Related Info